NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Adam Brufsky
University of Pittsburgh - Pittsburgh / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4700779
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Adam Brufsky's MOST POPULAR ARTICLES
1-)
Comprehensive molecular portraits of human breast tumoursBrigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...Nature 490 (7418), 61-70, 201297422012
2-)
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancerJA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...New England Journal of Medicine 379 (2), 111-121, 201815432018
3-)
Prospective validation of a 21-gene expression assay in breast cancerJA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...New England Journal of Medicine 373 (21), 2005-2014, 201513072015
4-)
RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor …NJ Robert, V Diéras, J Glaspy, AM Brufsky, I Bondarenko, ON Lipatov, ...Journal of clinical oncology 29 (10), 1252-1260, 201112282011
5-)
The CAG repeat within the androgen receptor gene and its relationship to prostate cancerE Giovannucci, MJ Stampfer, K Krithivas, M Brown, A Brufsky, J Talcott, ...Proceedings of the National Academy of Sciences 94 (7), 3320-3323, 199710861997
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept